The Philadelphia gene therapy company said the cuts were "part of a broader effort to right size the organization." ...

Dr. Singh took a pragmatic view of the booming biotech startup sector, which has grown from 50 startups in 2014 to over 11,000 today.

Clarissa Desjardins, CEO of Congruence Therapeutics, met Mr. Bellini 30 years ago as a young life sciences entrepreneur. In ...

Mr. Mahatme brings decades of experience in strategic finance, capital formation, and operational leadership to support ...

For the third time in four years, CNBC has ranked North Carolina as “America’s Top State for Business” in 2025.

A Maryland defense and space tech contractor is issuing its second round of pink slips this year.

Charles E. Hamner Jr., a highly respected and accomplished scientist, university administrator and pharmaceutical executive who led the North Carolina Biotechnology Center during its formative years, ...

Erica Carlisle, a veteran business management and strategy consultant in the pharmaceutical and biotechnology sectors, has a ...

An entrepreneur who founded one of the UK's most prominent biotechnology companies has secured funding for a new Midlands-based venture that aims to transform laboratory data management.

The FTC and DOJ's new approach to mergers and acquisitions could disrupt Utah’s dynamic life sciences ecosystem.

Syngene International Ltd., an integrated research, development, and manufacturing services organization, in partnership with ...